Gastric mucosa alterations in first-degree relatives of gastric cancer patients

Anticancer Research

Volumn 25, Issue 3 C, 2005, Pages 2567-2572

  Romiti, Adriana ^a   Zullo, Angelo ^b   Tomao, Silverio ^c   Hassan, Cesare ^b   Sarcina, Ida ^a   De Francesco, Vincenzo ^d   Ierardi, Enzo ^d   Tomao, Frederica ^c   Vecchione, Aldo ^a   Morini, Sergio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

catenin; Cell proliferation; E cadherin; Family history; Gastric cancer

Indexed keywords

BETA CATENIN; CELL ADHESION MOLECULE; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPY; ENZYME ASSAY; EPITHELIUM CELL; FEMALE; HELICOBACTER INFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RELATIVE; STOMACH BIOPSY; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH MUCOSA;

BETA CATENIN; CADHERINS; CASE-CONTROL STUDIES; CELL GROWTH PROCESSES; CYTOSKELETAL PROTEINS; EPITHELIAL CELLS; FAMILY HEALTH; FEMALE; GASTRIC MUCOSA; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

EID: 22944441928     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 80: 827-841, 1999.
2. Pisani P, Parkin DM, Bray F and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29, 1999.
3. Nardone G: Risk factor for cancer development in Helicobacter pylori gastritis. Dig Liver Dis 32(Suppl. 1): 190-192, 2000.
4. Nardone G: Molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther 17(Suppl. 2): 75-81, 2003.
5. Yatsuya H, Toyoshima H, Mizoue T, Kondo T, Tamakoshi K, Hori Y, Tokui N, Hoshiyama Y, Kikuchi S, Sakata K, Hayakawa N, Tamakoshi A Ohno Y and Yoshimura T: Family history and the risk of stomach cancer death in Japan: differences by age and gender. Int J Cancer 97: 688-694, 2002.
6. Bakir T, Can G, Erkul S and Siviloglu C: Stomach cancer history in the siblings of patients with gastric carcinoma. Eur J Cancer Prev 9: 401-408, 2000.
7. La Vecchia C, Negri E, Franceschi S and Gentile A: Family history and the risk of stomach and colorectal cancer. Cancer 70: 50-55, 1992.
8. Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, Fraumeni JF Jr and Buiatti E: Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 3: 15-18, 1994.
9. Lissowska J, Groves FD, Sobin LH, Fraumeni JF Jr, Nasierowska-Guttmejer A, Radziszewski J, Regula J, Hsing AW, Zatonski W, Blot WJ and Chow WH: Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev 8: 223-227, 1999.
10. Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G, Carriero A and Ponz de Leon M: Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66: 2047-2051, 1990.
11. Meining A, Hackelsberger A, Daenecke C, Stolte M, Bayerdorffer E and Ochsenkuhn T: Increased cell proliferation of the gastric mucosa in first-degree relatives of gastric carcinoma patients. Cancer 83: 876-881, 1998.
12. International Agency for Research on Cancer, World Health Organization. Infection with Helicobacter pylori. In: Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: IARC: pp. 177-202, 1994.
13. Huang JQ, Sridhar S, Chen Y and Hunt RH: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114: 1169-1179, 1998.
14. Ekstrom AM, Held M, Hansson LE, Engstrand L and Nyren O: The role of Helicobacter pylori in gastric cancer revised: CagA immunoblot as a marker of past infection. Gastroenterology 121: 784-791, 2001.
15. McNamara D and O'Morain C: Helicobacter pylori and gastric cancer. Ital J Gastroenterol Hepatol 30(Suppl. 3): 294-298, 1998.
16. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.
17. Buckley M and O'Morain C: Helicobacter pylori and gastric cancer. Eur J Cancer Prev 4: 139-144, 1995.
18. Zullo A, Rinaldi V, Hassan C, Diana F, Winn S, Castagna G and Attili AF: Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomised study. Aliment Pharmacol Ther 14: 1303-1309, 2000.
19. Zullo A, Romiti A, Rinaldi V, Vecchione A, Hassan C, Winn S, Tomao S and Attili AF: Gastric epithelial cell proliferation in patients with liver cirrhosis. Dig Dis Sci 46: 550-554, 2001.
20. Farkas R, Selmeci L, Tulassay Z and Pronai L: Superoxide-dismutase activity of the gastric mucosa in patients with Helicobacter pylori infection. Anticancer Res 23: 4309-4312, 2003.
21. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H and Dhom G: Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 88: 274-279, 2000.
22. Sepulveda A, Peterson LE, Shelton J, Gutierrez O and Graham DY: Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancer. Am J Gastroenterol 97: 1365-1370, 2002.
23. El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, Williams C, Fullarton G and McColl KE: Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 118: 22-30, 2000.
24. Meining AG, Bayerdorffer E and Stolte M: Helicobacter pylon gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol 11: 717-720, 1999.
25. Chang YW, Han YS, Lee DK, Kim HJ, Lim HS, Moon JS, Dong SH, Kim BH, Lee JI and Chang R: Role of Helicobacter pylori infection among offspring of siblings of gastric cancer patients. Int J Cancer 101: 469-474, 2002.
26. Guilford P: E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 5: 172-177, 1999.
27. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, Maung R, Seruca R, Jackson CE and Caldas C: Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 344: 1904-1909, 2001.
28. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W and Hommel G: Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69: 184-189, 1996.
29. Jawhari A, Jordan S, Poole S. Browne P, Pignatelli M and Farthing MJ: Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 112: 48-54, 1997.
30. Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC and Yang JM: Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 8: 987-993, 2002.
31. Ma M, Devereux TR, Stockton P, Sun K, Sills RC, Clayton N, Portier M and Flake G: Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp Toxic Pathol 53: 237-246, 2001.
32. Ierardi E, Francavilla A and Panella C: Effect of Helicobacter pylon eradication on intestinal metaplasia and gastric epithelium proliferation. Ital J Gastroenterol Hepatol 29: 470-475, 1997.
33. Cahill RJ, Kilgalleh C, Beattie S, Hamilton H and O'Morain C: Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 38: 177-181, 1996.
34. Anti M, Armuzzi A, Iascone E, Valenti A, Lippi ME, Covino M, Vecchio FM, Pierconti F, Buzzi A, Pignataro G, Bonvicini F and Gasbarrini G: Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis. Ital J Gastroenterol Hepatol 30: 153-159, 1998.
35. Ascano JJ, Frierson H Jr, Moskaluk CA, Harper JC, Roviello F, Jackson CE, El-Rifai W, Vindigni C, Tosi P and Powell SM: Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol 14: 942-949, 2001.
36. Blok P, Craanen ME, Dekker W and Tytgat GN: Loss of E-cadherin expression in early gastric cancer. Histopathology 34: 410-415, 1999.
37. Chan AO, Wong BC, Lan HY, Loke SL, Chan WK, Hui WM, Yuen YH, Ng I, Hou L, Wong WM, Yuen MF, Luk JM and Lam SK: Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J Gastroenterol Hepatol 18: 534-539, 2003.
38. Zullo A, Romiti A, Borrini F, Hassan C, Stella F, Sarcina I, Martini ME, Tomao S, Morini S and Mingazzini P: Alteration of E-cadherin expression in gastric mucosa: role of intestinal metaplasia and Helicobater pylori infection. Anticancer Res 24: 1603-1607, 2004.
39. Romiti A, Zullo A, Borrini F, Sarcina I, Hassan C, Winn S, Tomao S, Vecchione A, Morini S and Mingazzini P: Relationship between β-catenin expression and epithelial cell proliferation in gastric mucosa with intestinal metaplasia. World J Gastroenterol 11: i27, 2005.
40. Spina D, Vindigni C, Presenti L, Schurfeld K, Stumpo M and Tosi P: Cell proliferation, cell death, E-cadherin, metalloproteinase expression and angiogenesis in gastric cancer precursor and early cancer of the intestinal type. Int J Oncology 18: 1251-1258, 2001.
41. Grabsch H, Takeno S, Noguchi T, Hommel G, Gabbert HE and Mueller W: Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinico-pathological parameters and prognostic outcome. Histopathology 39: 141-149, 2001.
42. Gulmann C, Grace A, Leader M, Butler D, Patchett S and Kay E: Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays. Appl Immunohistochem Mol Morphol 11: 230-237, 2003.
43. Terres A M, Pajares J M, O'Toole D, Ahern S and Kelleher D: H. pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. J Clinic Pathol 51: 410-412, 1998.
44. Shun CT, Wu MS, Lin MT, Chang MC, Lin JT and Chuang SM: Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection. Oncology 60: 339-345, 2001.
45. Yu J, Ebert MP, Miehlke S, Rost H, Lendeckel U, Leodolter A, Stolte M, Bayerdorffer E and Malfertheiner P: Alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut 46: 639-644, 2000.
46. Ebert MP, Yu J, Miehlke S, Fei G, Lendeckel U, Ridwelski K, Stolte M, Bayerdorffer E and Malfertheiner P: Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br J Cancer 82: 1795-1800, 2000.
47. Yu J, Miehlke S, Ebert MP, Hoffman J, Breider TM, Alpen B, Starzynska T, Stolte M, Malfertheiner P and Bayerdorffer E: Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives. Cancer 88: 1801-1806, 2000.